BRAND_ANALYSIS#SANOFIHEALTH & PHARMA#17 OF 26 IN HEALTH & PHARMAALIGNED
Sanofi
· Private · Updated 22 Nov 2026 07:19 UTC
#806 of 1208 overall by tension · #17 of 26 in Health & Pharma
10Aligned
The Balanced
Analysis
Sanofi sits at C=50 and B=60, the profile of a pharmaceutical company that matters to the world far more than it matters to culture. At #806 with a tension score of 10, the scores hold steady, and in this sector that is closer to a virtue than a flaw. Its cultural relevance tends to arrive only in a crisis, which is both the job and the problem.
IN THE NEWS (100 articles this week)
Sanofi's pill becomes first US-approved drug for rare neurological disorder - Reuters
Big Pharma-backed Seawolf surfaces with $100M to hand, $1.2B Sanofi DNA med pact - Fierce Biotech
Facing down Dupixent cliff, Sanofi mulls buyout of Insmed and its blockbuster-to-be Brinsupri: Bloomberg - Fierce Pharma